Last $105.40 USD
Change Today +3.87 / 3.81%
Volume 442.9K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ALNYLAM PHARMACEUTICALS INC (ALNY)

Alnylam Pharmaceuticals, Inc. to Report Q4, 2014 on Feb 12, 2015
CapIQ 02/12/2015 9:30 PM ET
Alnylam Pharmaceuticals, Inc. to Report Q3, 2014 on Nov 05, 2014
CapIQ 02/12/2015 9:30 PM ET
Alnylam Pharmaceuticals, Inc. to Report Q2, 2014 on Aug 07, 2014
CapIQ 02/12/2015 9:30 PM ET

2013 revenues at Alnylam Pharmaceuticals, Inc. totaled $47.2M USD, while annual losses equaled $1.45 per share.

Quarterly Earnings & Estimates - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Quarterly Earnings

Alnylam Pharmaceuticals, Inc. reported 2nd quarter 2014 losses of $0.63 per share on 08/9/2014.

Annual Earnings & Estimates - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Annual Earnings

Alnylam Pharmaceuticals, Inc. reported annual 2013 losses of $1.45 per share on 02/15/2014.

Quarterly Revenues - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Quarterly Revenues

Alnylam Pharmaceuticals, Inc. had 2nd quarter 2014 revenues of $7.3M USD. This missed the $8.7M USD consensus estimate of the 3 analysts following the company. This was -16.0% below the prior year's 2nd quarter results.

Annual Revenues - ALNYLAM PHARMACEUTICALS INC (ALNY)

Actuals vs. Estimates for ALNYLAM PHARMACEUTICALS INC ALNY

Alnylam Pharmaceuticals, Inc.'s Annual Revenues

Alnylam Pharmaceuticals, Inc. had revenues for the full year 2013 of $47.2M USD. This was -29.3% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $105.40 USD +3.87

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Enzon Pharmaceuticals Inc $1.10 USD +0.05
Galena Biopharma Inc $1.81 USD +0.01
Regulus Therapeutics Inc $18.57 USD +0.05
Silence Therapeutics PLC 248.00 GBp 0.00
Tekmira Pharmaceuticals Corp C$22.45 CAD -0.10
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 154.5x
Price/Book 8.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 154.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.